These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25036934)

  • 1. Diabetic osteopenia by decreased β-catenin signaling is partly induced by epigenetic derepression of sFRP-4 gene.
    Mori K; Kitazawa R; Kondo T; Mori M; Hamada Y; Nishida M; Minami Y; Haraguchi R; Takahashi Y; Kitazawa S
    PLoS One; 2014; 9(7):e102797. PubMed ID: 25036934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
    Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
    Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.
    Lavergne E; Hendaoui I; Coulouarn C; Ribault C; Leseur J; Eliat PA; Mebarki S; Corlu A; Clément B; Musso O
    Oncogene; 2011 Jan; 30(4):423-33. PubMed ID: 20856206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
    Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
    Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression.
    Sato MM; Nakashima A; Nashimoto M; Yawaka Y; Tamura M
    Genes Cells; 2009 Feb; 14(2):141-53. PubMed ID: 19170762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
    Kitazawa R; Kitazawa S
    Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.
    Saito T; Mitomi H; Imamhasan A; Hayashi T; Mitani K; Takahashi M; Kajiyama Y; Yao T
    Virchows Arch; 2014 Feb; 464(2):135-43. PubMed ID: 24464051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats.
    Miao CG; Huang C; Huang Y; Yang YY; He X; Zhang L; Lv XW; Jin Y; Li J
    Cell Signal; 2013 Mar; 25(3):598-608. PubMed ID: 23200852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators.
    Bhuvanalakshmi G; Arfuso F; Kumar AP; Dharmarajan A; Warrier S
    Stem Cell Res Ther; 2017 Aug; 8(1):185. PubMed ID: 28807014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
    Manolagas SC; Almeida M
    Mol Endocrinol; 2007 Nov; 21(11):2605-14. PubMed ID: 17622581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The key role of proinflammatory cytokines, matrix proteins, RANKL/OPG and Wnt/β-catenin in bone healing of hip arthroplasty patients.
    Cassuto J; Folestad A; Göthlin J; Malchau H; Kärrholm J
    Bone; 2018 Feb; 107():66-77. PubMed ID: 29129760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.
    Marsit CJ; Karagas MR; Andrew A; Liu M; Danaee H; Schned AR; Nelson HH; Kelsey KT
    Cancer Res; 2005 Aug; 65(16):7081-5. PubMed ID: 16103055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of beta-catenin in postnatal bone acquisition.
    Holmen SL; Zylstra CR; Mukherjee A; Sigler RE; Faugere MC; Bouxsein ML; Deng L; Clemens TL; Williams BO
    J Biol Chem; 2005 Jun; 280(22):21162-8. PubMed ID: 15802266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.